Aurinia Pharmaceuticals Inc. reports

Company location: Edmonton, Alberta, Canada
Fiscal year end: 31 December

Aurinia Pharmaceuticals Inc. has filed 606 SEC EDGAR filings since 28 Feb 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G
40-F
6-K

SEC filing history

Showing 501-525 of 606 matching filings.

Per page

Current page

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 29 Dec 2016
Reporting date: 28 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

SUPPL File 333-206994

SUPPL #4

Filing date: 23 Dec 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SUPPL File 333-206994

SUPPL #4

Filing date: 22 Dec 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 22 Dec 2016
Reporting date: 22 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 19 Dec 2016
Reporting date: 19 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 13 Dec 2016
Reporting date: 13 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 12 Dec 2016
Reporting date: 12 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 21 Nov 2016
Reporting date: 21 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 16 Nov 2016
Reporting date: 16 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 10 Nov 2016
Reporting date: 10 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

FORM 6-K

Filing date: 09 Nov 2016
Reporting date: 09 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

6-K

Filing date: 09 Nov 2016
Reporting date: 09 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

FORM 6-K

Filing date: 09 Nov 2016
Reporting date: 09 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

SUPPL File 333-206994

SUPPL

Filing date: 09 Nov 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

REPORT OF FOREIGN ISSUER DATED NOVEMBER 4, 2016

Filing date: 07 Nov 2016
Reporting date: 30 Sep 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 07 Nov 2016
Reporting date: 04 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 02 Nov 2016
Reporting date: 02 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 24 Oct 2016
Reporting date: 24 Oct 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 11 Oct 2016
Reporting date: 11 Oct 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 06 Oct 2016
Reporting date: 06 Oct 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 30 Sep 2016
Reporting date: 29 Sep 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 26 Sep 2016
Reporting date: 22 Sep 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 26 Sep 2016
Reporting date: 21 Sep 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS 6-K

Filing date: 26 Sep 2016
Reporting date: 07 Sep 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

REPORT OF FOREIGN PRIVATE ISSUER DATED AUGUST 22, 2016

Filing date: 22 Aug 2016
Reporting date: 22 Aug 2016
SEC evidence: Open document Open filing
Next action: Verify source filing